Nathalie Pamir Selected Research

Nathalie Pamir Research Topics

Disease

6	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 11/2014
6	Atherosclerosis 01/2023 - 02/2016
6	Inflammation (Inflammations) 01/2022 - 03/2012
6	Insulin Resistance 11/2021 - 03/2003
5	Obesity 11/2021 - 04/2009
5	Body Weight (Weight, Body) 01/2018 - 04/2009
2	Hyperlipidemias (Hyperlipidemia) 01/2023 - 11/2021
2	Thrombosis (Thrombus) 01/2023 - 01/2023
2	Coronary Disease (Coronary Heart Disease) 11/2022 - 09/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2022 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 04/2009
2	Stroke (Strokes) 09/2021 - 10/2020
2	Acute-Phase Reaction 10/2020 - 02/2016
2	Weight Gain 01/2018 - 03/2003
2	Type 2 Diabetes Mellitus (MODY) 03/2003 - 01/2003
1	Hypertriglyceridemia 01/2024
1	Thrombotic Microangiopathies 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Myocardial Infarction 11/2022
1	Dyslipidemias (Dyslipidemia) 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Ischemic Stroke 10/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014
1	Pathologic Processes 09/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2003

Drug/Important Bio-Agent (IBA)

8	CholesterolIBA 10/2020 - 03/2012
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2003
4	HDL CholesterolIBA 11/2022 - 11/2014
4	Triglycerides (Triacylglycerol)IBA 09/2021 - 04/2009
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2016
4	Insulin (Novolin)FDA Link 01/2018 - 03/2003
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 01/2003
2	oxidized low density lipoproteinIBA 01/2023 - 01/2023
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 01/2023
2	LipidsIBA 11/2022 - 09/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2009
2	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2020
2	HDL LipoproteinsIBA 09/2021 - 10/2020
2	ProteomeIBA 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 09/2014 - 03/2012
2	Sucrose (Saccharose)IBA 04/2012 - 04/2009
1	Docosahexaenoic AcidsIBA 01/2024
1	Fish OilsIBA 01/2024
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2024
1	Eicosapentaenoic AcidIBA 01/2024
1	ibrutinibIBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	TicagrelorIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	von Willebrand FactorIBA 01/2023
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 11/2021
1	C-Reactive ProteinIBA 09/2021
1	Hedgehog ProteinsIBA 10/2020
1	ClusterinIBA 10/2020
1	arylesteraseIBA 10/2020
1	inter-alpha-inhibitorIBA 10/2020
1	Apolipoproteins MIBA 10/2020
1	apolipoprotein FIBA 10/2020
1	prenylcysteineIBA 10/2020
1	anthrax toxin receptorsIBA 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 10/2020
1	Aryldialkylphosphatase (Paraoxonase)IBA 10/2020
1	Phospholipase DIBA 10/2020
1	Inositol PhosphatesIBA 10/2020
1	Polysaccharides (Glycans)IBA 10/2020
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 10/2020
1	ApolipoproteinsIBA 10/2020
1	Amyloid (Amyloid Fibrils)IBA 10/2020
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 10/2020
1	OxysterolsIBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	Antisense OligonucleotidesIBA 01/2020
1	Lipoprotein(a)IBA 10/2019
1	Ketoglutarate Dehydrogenase Complex (Oxoglutarate Dehydrogenase)IBA 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 02/2016
1	Apolipoproteins B (ApoB)IBA 02/2016
1	EnzymesIBA 09/2014
1	Metalloproteases (Metalloproteinases)IBA 09/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2014
1	Matrix Metalloproteinase 12IBA 09/2014
1	Lymphotoxin-alpha (Lymphotoxin)IBA 04/2012
1	CR 6IBA 03/2012
1	Apolipoprotein A-VIBA 04/2009
1	Blood Glucose (Blood Sugar)IBA 03/2003
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2003
1	IncretinsIBA 03/2003

Therapy/Procedure

1	Caloric Restriction 03/2012